Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK

PloS one

Long-Sheng Chang, Janet L Oblinger, Abbi E Smith, …, Gary L Johnson, Jaishri O Blakeley, D Wade Clapp

• DOI: 10.1371/journal.pone.0252048
• PMID: 34264955
• PMCID: PMC8282008